- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Neoplasms, Castration-Resistant in New Zealand
Total 1258 results
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
William K. OhProstate Cancer FoundationCompleted
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Rockefeller UniversityMemorial Sloan Kettering Cancer CenterCompleted
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
AstraZenecaCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)Completed
-
Memorial Sloan Kettering Cancer CenterAmbrilia Biopharma, Inc.CompletedProstate CancerUnited States
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
NYU Langone HealthTerminated
-
NYU Langone HealthCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Beth Israel Medical CenterBayerTerminatedProstate CancerUnited States
-
Columbia UniversityCelgene CorporationCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Rockefeller UniversityCompletedSafety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterPSMA Development Corp, LLCCompleted
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); AbbVie; Rutgers Cancer Institute of New JerseyTerminated
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Terminated
-
Novartis PharmaceuticalsCompletedProstate CancerSaudi Arabia, Taiwan, Korea, Republic of, Lebanon, Brazil, China, New Zealand, Australia, Thailand, Kuwait
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedProstate Cancer | Precancerous/Nonmalignant ConditionUnited States
-
KangLaiTe USATerminated
-
Yale UniversityCompleted
-
NYU Langone HealthTerminatedProstate CancerUnited States
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
New York Prostate InstituteSanofiUnknownProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMRI | Prostate CancerUnited States
-
Johnson & Johnson Private LimitedWithdrawn
-
Roswell Park Cancer InstituteTerminated
-
Maimonides Medical CenterCompleted
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Terminated
-
New Mexico Cancer Care AllianceTerminatedProstate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCapcureCompletedCancer | ProstateUnited States
-
Memorial Sloan Kettering Cancer CenterNo longer availableRecurrent Prostate Cancer | Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of North Carolina; New York-Presbyterian Hospital Cornell Medical...CompletedPain | Metastatic Prostate CancerUnited States